Epigallocatechin Gallate Protects against MNNG-Induced Precancerous Lesions of Gastric Carcinoma in Rats via PI3K/Akt/mTOR Pathway

OBJECTIVE: To evaluate the therapeutic effect of epigallocatechin gallate (EGCG) on precancerous lesions of gastric carcinoma (PLGC) and to determine whether EGCG protects against PLGC by regulating PI3K/Akt/mTOR pathway. METHODS: Twenty-four male Wistar rats were randomly divided into 3 groups: nor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Feiye, Xu, Yanli, Pan, Jieli, Li, Meiya, Chen, Fangming, Xie, Guanqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880711/
https://www.ncbi.nlm.nih.gov/pubmed/33628319
http://dx.doi.org/10.1155/2021/8846813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880711/
https://www.ncbi.nlm.nih.gov/pubmed/33628319
http://dx.doi.org/10.1155/2021/8846813

Ejemplares similares